Latitude Advisors, LLC Moderna, Inc. Transaction History

Latitude Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$117.13 - $176.59 $144,069 - $217,205	-1,230 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$126.46 - $235.05 $51,848 - $96,370	410 Added 50.0%	1,230 $212,000
Q3 2021 Oct 14, 2021	BUY	$221.9 - $484.47 $181,958 - $397,265	820 New	820 $316,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Latitude Advisors, LLC with notifications on news.